Skip to main content

Endoscopic Methods for Lung Volume Reduction

  • Chapter
  • First Online:
Interventions in Pulmonary Medicine
  • 583 Accesses

Abstract

Pulmonologists have been investigating a variety of minimally invasive alternatives to lung volume reduction surgery for years. Endoscopic lung volume reduction can be defined as a minimally invasive bronchoscopic procedure devoted to the reduction in total or regional lung volumes in patients with severe emphysema and significant exertional dyspnea. The methods are diverse, but rely for the most part on the flexible bronchoscope using deep sedation or general anesthesia. Most procedures last less than 1 h and may target one or both lungs. Patients may undergo pulmonary rehabilitation prior to treatment, and must be on standard medical therapy for chronic obstructive pulmonary disease (COPD), including bronchodilators and occasionally low-dose steroids. Endoscopic lung volume reduction has also been postulated as a bridge to lung transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348(21):2059–73.

    Google Scholar 

  2. National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med. 2001;345(15):1075–83.

    Google Scholar 

  3. Decker MR, Leverson GE, Jaoude WA, Maloney JD. Lung volume reduction surgery since the National Emphysema Treatment Trial: study of Society of Thoracic Surgeons Database. J Thorac Cardiovasc Surg. 2014;148(6):2651–8.

    PubMed  PubMed Central  Google Scholar 

  4. Attaway AH, Hatipoglu U, Murthy S, Zein J. Lung volume reduction surgery in the United States from 2007 to 2013 increasing volumes and reason for caution. Chest. 2019;155(5):1080–1.

    PubMed  Google Scholar 

  5. Stanifer BP, Ginsburg ME. Lung volume reduction surgery in the post-National Emphysema Treatment Trial era. J Thorac Dis. 2018;10(Suppl 23):S2744–7.

    PubMed  PubMed Central  Google Scholar 

  6. Maxfield RA. New and emerging minimally invasive techniques for lung volume reduction. Chest. 2004;125:777–83.

    PubMed  Google Scholar 

  7. Toma TP. The flexible bronchoscopic approach to lung volume reduction. Pneumologia. 2001;50:97–100.

    CAS  PubMed  Google Scholar 

  8. Mantri S, Macaraeg C, Shetty S, et al. Technical advances: measurement of collateral flow in the lung with a dedicated endobronchial catheter system. J Bronchology Interv Pulmonol. 2009;16(2):141–4.

    PubMed  Google Scholar 

  9. Herth FJ, Eberhardt R, Gompelman D, et al. Radiological and clinical outcomes of using Chartis to plan endobronchial valve treatment. Eur Respir J. 2013;41:302–8.

    PubMed  Google Scholar 

  10. Schuhmann M, Raffy P, Yin Y, et al. Computed tomography predictors of response to endobronchial valve lung reduction treatment. Comparison with Chartis. Am J Respir Crit Care Med. 2015;191:767–74.

    PubMed  Google Scholar 

  11. Hillerdal G, Mindus S. One- to four-year follow-up of endobronchial lung volume reduction in alpha-1-antitrypsin deficiency patients: a case series. Respiration. 2014;88(4):320–8.

    CAS  PubMed  Google Scholar 

  12. Perotin JM, Leroy S, Marquette CH, et al. Endobronchial coil treatment in severe emphysema patients with alpha-1 antitrypsin deficiency. Int J COPD. 2018;13:3645–9.

    CAS  Google Scholar 

  13. Lenga P, Ruwwe-Glösenkamp C, Grah C, et al. Endoscopic lung volume reduction with endobronchial valves in very low DLCO patients: results from the German Registry. ERJ Open Res. 2021;7:00449–2020.

    PubMed  PubMed Central  Google Scholar 

  14. Trudzinski FC, Höink AJ, Leppert D, et al. Endoscopic lung volume reduction using endobronchial valves in patients with severe emphysema and very low FEV1. Respiration. 2016;92(4):258–65.

    PubMed  Google Scholar 

  15. Sciurba F, Ernst A, Herth F, et al. For the VENT study research group a randomized study of endobronchial valves for advanced emphysema. N Engl J Med. 2010;363:1233–44.

    CAS  PubMed  Google Scholar 

  16. http://www.fda.gov/ohrms/dockets/ac/08/transcripts/2008-4404-t001.pdf.

  17. Sciurba F, Goldin J, Criner GJ, et al. Endobronchial valves for emphysema. N Engl J Med. 2011;364:381–4.

    Google Scholar 

  18. Hopkinson NS, Kemp SV, Toma TP, et al. Atelectasis and survival after bronchoscopic lung volume reduction for COPD. Eur Respir J. 2011;37:1346–51.

    CAS  PubMed  Google Scholar 

  19. Davey C, Zoumot Z, Jordan S, et al. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial. Lancet. 2015;386:1066–73.

    PubMed  Google Scholar 

  20. Klooster K, ten Hacken NH, Hartman JE, Kerstjens HAM, van Rikxoort EM, Slebos DJ. Endobronchial valves for emphysema without interlobar collateral ventilation. N Engl J Med. 2015;373:2325–35.

    CAS  PubMed  Google Scholar 

  21. Kemp SV, Slebos DJ, Kirk A, et al. A multicenter RCT of Zephyr® endobronchial valve treatment in heterogeneous emphysema (TRANSFORM). Am J Respir Crit Care Med. 2017;196:1535–43.

    PubMed  Google Scholar 

  22. Criner GJ, Sue R, Wright S, et al. A multicenter RCT of Zephyr® endobronchial valve treatment in heterogeneous emphysema (LIBERATE). Am J Respir Crit Care Med. 2018;198:1151–64.

    PubMed  Google Scholar 

  23. Venuta F, Anile M, Diso D, et al. Long-term follow-up after bronchoscopic lung volume reduction in patients with emphysema. Eur Respir J. 2012;39:1084–9.

    PubMed  Google Scholar 

  24. Garner J, Kemp SV, Toma TP, Hansell DM, Polkey MI, Shah PL, Hopkinson NS. Survival after endobronchial valve placement for emphysema: a 10-year follow-up study. Am J Respir Crit Care Med. 2016;194:519–21.

    PubMed  PubMed Central  Google Scholar 

  25. Ninane V, Geltner C, Bezzi M, et al. Multicentre European study for the treatment of advanced emphysema with bronchial valves. Eur Respir J. 2012;39:1319–25.

    PubMed  Google Scholar 

  26. Wood DE, Nader DA, Springmeyer SC, et al. IBV Valve Trial Research Team.The IBV valve trial: a multicenter, randomized, double-blind trial of endobronchial therapy for severe emphysema. J Bronchology Interv Pulmonol. 2014;21(4):288–97.

    PubMed  Google Scholar 

  27. Springmeyer SC, Bolliger CT, Waddell TK, et al. Treatment of heterogeneous emphysema using the spiration IBV valves. Thorac Surg Clin. 2009;19:247–53.

    PubMed  Google Scholar 

  28. Criner GJ, Delage A, Voelker K, et al. Improving lung function in severe heterogenous emphysema with the Spiration valve system (EMPROVE). A multicenter, open-label randomized controlled clinical trial. Am J Respir Crit Care Med. 2019;200:1354–62.

    PubMed  PubMed Central  Google Scholar 

  29. Castro M, Rubin AS, Laviolette M, Fiterman J, De Andrade M, Shah PL. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma. A multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med. 2010;181:116–24.

    PubMed  PubMed Central  Google Scholar 

  30. Lausberg HF, Chino K, Patterson GA, et al. Bronchial fenestration improves expiratory flow in emphysematous human lungs. Ann Thorac Surg. 2003;75:393–7.

    PubMed  Google Scholar 

  31. Chong CK, Phan L, Massetti P, et al. Prolongation of patency of airway bypass stents with use of drug-eluting stents. J Thorac Cardiovasc Surg. 2006;131:60–4.

    Google Scholar 

  32. Cardoso PF, Snell GI, Hopkins P, et al. Clinical application of airway bypass stents with paclitaxel eluting stents: early results. J Thorac Cardiovasc Surg. 2007;134:974–81.

    PubMed  Google Scholar 

  33. Shah PL, Slebos J, Cardoso PFG, et al. Bronchoscopic lung-volume reduction with exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial. Lancet. 2011;378:997–1005.

    CAS  PubMed  Google Scholar 

  34. Gompelmann D, Eberhardt R, Herth F. Endoscopic lung volume reduction: a European perspective. Ann Am Thorac Soc. 2013;10(6):657–66.

    PubMed  Google Scholar 

  35. Ingenito EP, Berger RL, Henderson AC, et al. Bronchoscopic lung volume reduction using tissue engineering principles. Am J Respir Crit Care Med. 2003;167:771–8.

    PubMed  Google Scholar 

  36. Reilly J, Washko G, Pinto-Plata V, et al. Biological lung volume reduction: a new bronchoscopic therapy for advanced emphysema. Chest. 2007;131:1108–13.

    PubMed  Google Scholar 

  37. Criner GJ, Pinto-Plata V, Strange C, et al. Biologic lung volume reduction in advanced upper lobe emphysema: phase 2 results. Am J Respir Crit Care Med. 2009;179:791–8.

    PubMed  Google Scholar 

  38. Refaely Y, Dransfield M, Krameer MR, et al. Biologic lung volume reduction therapy for advanced homogeneous emphysema. Eur Respir J. 2010;36:20–7.

    CAS  PubMed  Google Scholar 

  39. Magnussen H, Kramer MR, Kirsten AM, et al. Effect of fissure integrity on lung volume reduction using a polymer sealant in advanced emphysema. Thorax. 2012;67:302–8.

    PubMed  Google Scholar 

  40. Come CE, Kramer MR, Dransfield MT, et al. A randomised trial of lung sealant versus medical therapy for advanced emphysema. Eur Respir J. 2015;46:651–62.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Herth FJ, Eberhardt R, Gomplemann D, Slebos DJ, Ernst A. Bronchoscopic lung volume reduction with a dedicated coil: a clinical pilot study. Ther Adv Respir Dis. 2010;4:225–31.

    PubMed  Google Scholar 

  42. Slebos DJ, Klooster K, Ernst A, Herth F, Kerstjens H. Bronchoscopic lung volume reduction coil treatment of patients with severe heterogeneous emphysema. Chest. 2012;142:574–82.

    PubMed  Google Scholar 

  43. Shah PL, Zoumot Z, Singh S, et al. Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial. Lancet Respir Med. 2013;1:233–40.

    PubMed  Google Scholar 

  44. Deslee G, Klooster K, Hetzel M, et al. Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial. Thorax. 2014;69:980–6.

    PubMed  Google Scholar 

  45. Deslée G, Mal H, Dutau H, et al. Lung volume reduction coil treatment vs usual care in patients with severe emphysema: the REVOLENS randomized clinical trial. JAMA. 2016;315(2):175–84.

    PubMed  Google Scholar 

  46. Sciurba FC, Criner GJ, Strange C, et al. Effect of endobronchial coils vs usual care on exercise tolerance in patients with severe emphysema. JAMA. 2016;315(20):2178–89.

    CAS  PubMed  Google Scholar 

  47. Slebos DJ, Cicenia J, Sciurba FC, et al. RENEW StudyGroup. Predictors of response to endobronchial coil therapy in patients with advanced emphysema. Chest. 2019;155:928–37.

    PubMed  Google Scholar 

  48. Herth FJ, Ernst A, Baker KM, et al. Characterization of outcomes 1 year after endoscopic thermal vapor ablation for patients with heterogeneous emphysema. Int J Chron Obstruct Pulmon Dis. 2012;7:397–405.

    PubMed  PubMed Central  Google Scholar 

  49. Herth FJ, Valipour A, Shah PL, et al. Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial. Lancet Respir Med. 2016;4(3):185–93.

    PubMed  Google Scholar 

  50. Joglekar MM, Slebos DJ, Leijten J, Burgess JK, Pouwels SD. Crosslink bio-adhesives for bronchoscopic lung volume reduction: current status and future directions. Eur Respir Rev. 2021;30:210142.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luis M. Seijo Maceiras .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Seijo Maceiras, L.M. (2023). Endoscopic Methods for Lung Volume Reduction. In: Díaz-Jiménez, J.P., Rodríguez, A.N. (eds) Interventions in Pulmonary Medicine. Springer, Cham. https://doi.org/10.1007/978-3-031-22610-6_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-22610-6_35

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-22609-0

  • Online ISBN: 978-3-031-22610-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics